Raymond Reeves
#162,292
Most Influential Person Now
Raymond Reeves's AcademicInfluence.com Rankings
Raymond Reevesbiology Degrees
Biology
#12933
World Rank
#16441
Historical Rank
Biochemistry
#2235
World Rank
#2381
Historical Rank
Download Badge
Biology
Why Is Raymond Reeves Influential?
(Suggest an Edit or Addition)Raymond Reeves's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intrinsically disordered protein. (2001) (1491)
- Sodium butyrate inhibits histone deacetylation in cultured cells (1978) (894)
- High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. (1996) (736)
- The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. (1990) (640)
- Molecular biology of HMGA proteins: hubs of nuclear function. (2001) (538)
- The solution structure of an HMG-I(Y)–DNA complex defines a new architectural minor groove binding motif (1997) (357)
- HMGI/Y proteins: flexible regulators of transcription and chromatin structure. (2001) (346)
- Transcriptionally active chromatin. (1984) (311)
- Network of Dynamic Interactions between Histone H1 and High-Mobility-Group Proteins in Chromatin (2004) (265)
- Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells (2001) (254)
- Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y (1989) (243)
- Nuclear functions of the HMG proteins. (2010) (221)
- The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences (1994) (210)
- Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). (1988) (175)
- The influence of DNA and nucleosome structure on integration events directed by HIV integrase. (1994) (175)
- Evidence for a shared structural role for HMG1 and linker histones B4 and H1 in organizing chromatin. (1996) (156)
- Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. (1998) (143)
- High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes (1989) (133)
- HMG Protein Family Members Stimulate Human Immunodeficiency Virus Type 1 and Avian Sarcoma Virus Concerted DNA Integration In Vitro (1999) (127)
- Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. (2000) (126)
- High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. (1996) (123)
- A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation (1992) (120)
- Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. (1991) (114)
- Sodium butyrate stimulates DNA repair in UV-irradiated normal and xeroderma pigmentosum human fibroblasts. (1982) (113)
- Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. (1991) (110)
- Sodium butyrate induces new gene expression in Friend erythroleukemic cells. (1979) (109)
- Why target PIM1 for cancer diagnosis and treatment? (2010) (106)
- Structure and function of the HMGI(Y) family of architectural transcription factors. (2000) (106)
- Role of high mobility group (HMG) chromatin proteins in DNA repair. (2005) (106)
- Trichomonosis, a Common Curable STI, and Prostate Carcinogenesis—A Proposed Molecular Mechanism (2012) (105)
- PIM1 Phosphorylates and Negatively Regulates ASK1-mediated Apoptosis (2009) (102)
- Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3' untranslated region of bovine interleukin 2 cDNA. (1987) (102)
- Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E. (1997) (96)
- HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells (2012) (95)
- The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? (2008) (93)
- Changes in Superhelicity Are Introduced into Closed Circular DNA by Binding of High Mobility Group Protein I/Y (*) (1995) (93)
- Recruitment of SWI/SNF to the Human Immunodeficiency Virus Type 1 Promoter (2004) (89)
- Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. (1993) (89)
- Recombinant human pim-1 protein exhibits serine/threonine kinase activity. (1991) (88)
- HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. (1997) (82)
- Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA. (1996) (81)
- Interaction of high mobility group-I (Y) nonhistone proteins with nucleosome core particles. (1993) (80)
- Enhanced recovery of a secreted mammalian protein from suspension culture of genetically modified tobacco cells. (1996) (79)
- Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation. (1990) (79)
- Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. (1986) (77)
- The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. (2007) (75)
- Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1 (1989) (73)
- High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-κB Binding and Transactivation of the Inducible Nitric-oxide Synthase Promoter/Enhancer* (1999) (71)
- The Role of High-Mobility Group I(Y) Proteins in Expression of IL-2 and T Cell Proliferation1 (2000) (70)
- Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence. (1992) (70)
- High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells. (2015) (68)
- Binding of HMG-I(Y) Imparts Architectural Specificity to a Positioned Nucleosome on the Promoter of the Human Interleukin-2 Receptor α Gene (2000) (67)
- Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. (2000) (64)
- The Human IL-2 Gene Promoter Can Assemble a Positioned Nucleosome That Becomes Remodeled Upon T Cell Activation1 (2002) (63)
- Purification and assays for high mobility group HMG-I(Y) protein function. (1999) (62)
- Genomic transcriptional activity and the structure of chromatin (1976) (61)
- High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells (2004) (61)
- Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. (2005) (59)
- Carbohydrate modifications of the high mobility group proteins. (1981) (59)
- Molecular cloning of a functional bovine interleukin 2 cDNA. (1986) (56)
- Inhibition of Nucleotide Excision Repair by High Mobility Group Protein HMGA1* (2005) (54)
- Ribosomal genes of Xenopus laevis: evidence of nucleosomes in transcriptionally active chromatin. (1976) (53)
- Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation (2004) (52)
- Differential Regulation of a Multipromoter Gene. (1995) (49)
- Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. (2007) (48)
- Characterizing metabolic changes in human colorectal cancer (2015) (47)
- Hoechst 33258, distamycin A, and high mobility group protein I (HMG-I) compete for binding to mouse satellite DNA (1992) (46)
- FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo. (2000) (46)
- The non‐histone chromosomal protein HMG‐I(Y) contributes to repression of the immunoglobulin heavy chain germ‐line ε RNA promoter (1995) (46)
- Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. (1999) (46)
- Metabolomics of colorectal cancer: past and current analytical platforms (2013) (45)
- In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. (2004) (45)
- HMGA proteins: flexibility finds a nuclear niche? (2003) (44)
- Partial inhibition of histone deacetylase in active chromatin by HMG 14 and HMG 17. (1980) (44)
- Chromatin changes during the cell cycle. (1992) (43)
- Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction (1989) (43)
- High-Mobility-Group Protein I Can Modulate Binding of Transcription Factors to the U5 Region of the Human Immunodeficiency Virus Type 1 Proviral Promoter (2000) (42)
- Investigations of the possible functions for glycosylation in the high mobility group proteins. Evidence for a role in nuclear matrix association. (1983) (41)
- Dynamic mitochondrial localization of nuclear transcription factor HMGA1. (2005) (40)
- Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-β1* (2001) (40)
- Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. (1991) (40)
- Characterization of the testes-specific pim-1 transcript in rat. (1992) (39)
- Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells. (2010) (39)
- Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells (2004) (37)
- Specific A . T DNA sequence binding of RP-HPLC purified HMG-I. (1987) (37)
- Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells (1998) (36)
- Constitutive IL-2 mRNA expression in lymphocytes, infected with the intracellular parasite Theileria parva. (1992) (36)
- Structure of Xenopus ribosomal gene chromatin during changes in genomic transcription rates. (1978) (35)
- A conformational study of the sequence specific binding of HMG-I (Y) with the bovine interleukin-2 cDNA. (1988) (34)
- HMGA1a: sequence‐specific RNA‐binding factor causing sporadic Alzheimer's disease‐linked exon skipping of presenilin‐2 pre‐mRNA (2007) (33)
- Nucleosome structure of Xenopus oocyte amplified ribosomal genes. (1978) (32)
- High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. (2007) (32)
- Cell cycle regulation and functions of HMG-I(Y). (1995) (32)
- The HMG-I(Y) A·T-hook Peptide Motif Confers DNA-binding Specificity to a Structured Chimeric Protein* (1999) (31)
- Silencer Activity in the Interferon-A Gene Promoters* (1997) (31)
- Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. (2001) (31)
- HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis. (2015) (29)
- Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome. (2002) (28)
- HMGA proteins as therapeutic drug targets. (2003) (28)
- HMGA1 Levels Influence Mitochondrial Function and Mitochondrial DNA Repair Efficiency (2009) (27)
- Expression and characterization of the interleukin 2 receptor in Theileria parva‐infected bovine lymphocytes (1989) (27)
- Distamycin A Inhibits HMGA1-Binding to the P-Selectin Promoter and Attenuates Lung and Liver Inflammation during Murine Endotoxemia (2010) (27)
- Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). (1988) (25)
- Dynamic and Differential in Vivo Modifications of the Isoform HMGA1a and HMGA1b Chromatin Proteins* (2005) (25)
- 1H and 13C NMR assignments and molecular modelling of a minor groove DNA-binding peptide from the HMG-I protein. (2009) (25)
- Turnover of histone acetyl groups in cultured cells is inhibited by sodium butyrate (1978) (24)
- Microheterogeneity of the mammalian high-mobility group proteins 14 and 17 investigated by reverse-phase high-performance liquid chromatography. (1985) (24)
- Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro. (1999) (23)
- Butyrate suppression of position-effect variegation in Drosophila melanogaster (2004) (22)
- Mechanisms regulating transient expression of mammalian cytokine genes and cellular oncogenes. (1990) (21)
- HMGA1 Co-activates Transcription in B Cells through Indirect Association with DNA* (2003) (21)
- Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins. (2007) (21)
- Evidence for two discrete phases of IL-2 production in bovine lymphocytes. (1988) (20)
- Recombination of exogenous interleukin 2 receptor gene flanked by immunoglobulin recombination signal sequences in a pre-B cell line and transgenic mice. (1991) (20)
- Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. (1995) (18)
- Base-Pair Substitutions in Avian Sarcoma Virus U5 and U3 Long Terminal Repeat Sequences Alter the Process of DNA Integration In Vitro (2001) (17)
- Replacement of conserved threonines by alanine residues in high mobility group protein HMG-I(Y): effect on DNA binding affinity. (1995) (15)
- Analysis and reconstruction of Xenopus ribosomal chromatin nucleosomes. (1977) (15)
- Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1β in Vascular Smooth Muscle Cells (1999) (15)
- Combined use of regulatory elements within the cDNA to increase the production of a soluble mouse single-chain antibody, scFv, from tobacco cell suspension cultures. (2002) (15)
- The Role of High-Mobility Group I(Y) Proteins in Expression of IL-2 and T Cell Proliferation (2000) (14)
- Bovine interleukin 2: regulatory mechanisms. (1987) (14)
- HMGA proteins: isolation, biochemical modifications, and nucleosome interactions. (2004) (14)
- HMGA1 enhances the transcriptional activity and binding of the estrogen receptor to its responsive element. (2002) (14)
- Bovine leukemia virus transmembrane protein gp30 physically associates with the down-regulatory phosphatase SHP-1. (1999) (13)
- A rapid method for the large scale preparation of bovine leukemia virus antigen. (1988) (12)
- IL-2 can enhance the cyclosporin A-mediated inhibition of Theileria parva-infected T cell proliferation. (1990) (11)
- Constitutive synthesis of globins within most of the members of an uninduced, proliferating population of Friend erythroluekemic cells. (1979) (11)
- The effects of oxidation on the reverse-phase high-performance liquid chromatography characteristics of the high mobility groups 1 and 2 proteins. (1985) (11)
- Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer. (2016) (10)
- Clusterin Gene in Rat Sertoli Cells Is Regulated by a Core-Enhancer Element (2000) (10)
- Effect of DNase I on histone acetyltransferase and deacetylase enzyme activities in Friend cell nuclei: evidence for a putative inhibitor of the deacetylase enzymes in transcriptionally active chromatin. (1979) (9)
- Frontline Science: Targeted expression of a dominant‐negative high mobility group A1 transgene improves outcome in sepsis (2018) (8)
- NMR resonance assignments of the human high mobility group protein HMGA1 (2007) (7)
- Non-histone chromatin proteins that recognize specific sequences of DNA. (1987) (6)
- HMG Nuclear Proteins: Linking Chromatin Structure to Cellular Phenotype (2010) (6)
- The functional interaction between HMGA1 and the estrogen receptor requires either the N‐ or the C‐terminal domain of the receptor (2004) (6)
- Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism. (2002) (4)
- Microheterogeneity of the mammalian high mobility group (HMG) proteins 1 and 2 investigated by reverse-phase high performance liquid chromatography. (1985) (4)
- Effect of dexamethasone on the expression of interleukin-2 in a mouse T cell line. (1989) (4)
- The HMGA1a-STAT3 axis: an “Achilles Heel” for Hematopoietic Malignancies Overexpressing HMGA1a? (2008) (3)
- Characterization of the bovine receptor(s) for interleukin-2. (1989) (3)
- HMGA proteins: multifaceted players in nuclear function (2004) (2)
- ProliferationProteins in Expression of IL-2 and T Cell The Role of High-Mobility Group I(Y) (2000) (2)
- Persistent Infection ofRabbits withBovine Leukemia Virus Associated withDevelopment ofImmuneDysfunction (1989) (0)
- Table of Contents (1996) (0)
- Virus Type 1 Proviral Promoter Region of the Human Immunodeficiency Binding of Transcription Factors to the U 5 High-Mobility-Group Protein I Can Modulate (2000) (0)
- STAT3: An HMGA1 gene target involved in HMGA1-mediated leukemogenesis and possible therapeutic target (2007) (0)
- The role of architectural transcription factors in IL-2 dependent T cells proliferation (2001) (0)
- OF THE * H NMR SPECTRUM OF A CONSENSUS DNA-BINDING PEPTIDE FROM THE HMG-I PROTEIN (2007) (0)
- Construction and Transfer into Mammalian Cells of a Vector Containing Insect Histone Genes (1983) (0)
- HMGA1 proteins act as transcriptional regulators within the mitochondria and alter organelle related cellular function (2006) (0)
- Becomes Remodeled Upon T Cell Activation Assemble a Positioned Nucleosome That The Human IL-2 Gene Promoter Can (2002) (0)
- Developing an RNAi based approach to silence the expression of HMGAI proteins in human mammalian epithelial cells (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Raymond Reeves?
Raymond Reeves is affiliated with the following schools:
